New Products In Brief
This article was originally published in The Rose Sheet
The “first-ever CC cream for hair” debuts, along with new lipsticks from Dr. Hauschka and skin-care offerings of a more traditional design from anti-wrinkle patch brand BIOBLISS. More new products in brief.
You may also be interested in...
Regulators want to know who is interested in joining their planned multi-stakeholder platform for discussions on how to improve clinical trials in Europe. They are also seeking feedback on which topics should be prioritized for discussion.
Sandoz has confirmed that its denosumab biosimilar BLA has been accepted for review by the US FDA. The company – which has previously characterized its development program as a frontrunner compared to other proposed Prolia/Xgeva rivals – indicated that it was “among the first” to file.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.